Agilent licenses Caliper's diagnostic technology.Caliper caliper Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving. Life Sciences, Inc. (Palo Alto Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , CA) and Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Inc. (Hopkinton, MA) formed an agreement granting Agilent a non-exclusive license to use a majority of Caliper's microfluidics patent estate for the development of clinical diagnostic applications on Agilent's 2100 Bioanalyzer, its 5100 Automated au·to·mate v. au·to·mat·ed, au·to·mat·ing, au·to·mates v.tr. 1. To convert to automatic operation: automate a factory. 2. Lab-on-a-Chip platform and future instrument platforms. This new license agreement leverages the expertise and leading technology of Caliper and Agilent, enabling both companies to capitalize on Cap´i`tal`ize on` v. t. 1. To turn (an opportunity) to one's advantage; to take advantage of (a situation); to profit from; as, to capitalize on an opponent's mistakes s>. the burgeoning diagnostics market. Under a separate new supply agreement, Agilent will use Caliper as its exclusive supplier of planar A technique developed by Fairchild Instruments that creates transistor sublayers by forcing chemicals under pressure into exposed areas. Planar superseded the mesa process and was a major step toward creating the chip. LabChip products for the 2100 Bioanalyzer and future instrument platforms for the next five years. The diagnostics license agreement is part of Caliper's "LabChip Driven" program, under which the company licenses its LabChip technology to developers of innovative products and services. Under the terms of this agreement, Agilent will pay an upfront licensing fee to Caliper, plus royalties on future sales of diagnostics LabChip products covered under the agreement. Further details of the two new agreements were not disclosed. "Our years of success with the 2100 Bioanalyzer product line have demonstrated the long-term value of Caliper's LabChip technology for life science research, and this technology holds tremendous promise for other markets," said Chris Van Ingen, President, Life Science and Chemical Analysis at Agilent. "Human clinical diagnostics is a major opportunity for Agilent, and we see synergy The enhanced result of two or more people, groups or organizations working together. In other words, one and one equals three! It comes from the Greek "synergia," which means joint work and cooperative action. in combining microfluidics technology with Agilent's broad systems expertise. Our partnership with Caliper has been very productive, and we look forward to continuing to leverage both companies' expertise to deliver innovative solutions for our customers." "Adding the Agilent diagnostic license to our LabChip Driven program is an important milestone for our business," said Kevin Hrusovsky, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. at Caliper. "We believe our LabChip technology will play a leading role in the evolution of the diagnostics market as personalized medicine Hrusovsky added, "Our new long-term chip supply agreement with Agilent cements our position as a leading microfluidic chip supplier and signifies a continued collaborative and productive future relationship between our companies." Caliper also updated revenue guidance for 2005. Based on preliminary financial data, Caliper expects second quarter revenue to be at the top end of the previously announced range of $17 million to $20 million. The company also reaffirmed its previous revenue projection for the full year of $84 million to $90 million. Agilent Technologies is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 28,000 employees serve customers in more than 110 countries. Agilent has net revenue of $7.2 billion in fiscal year 2004. Information about Caliper Life Sciences uses its advanced liquid handling and LabChip technologies to create leading edge tools that accelerate drug discovery, enable diagnosis of disease and facilitate scientific research. Caliper headquarters are located in Hopkinton, Massachusetts Hopkinton is a town located in southwestern Middlesex County, Massachusetts, about 40 km (26.4 mi) from Boston. It is one of nine towns that are part of the region known as MetroWest. The population was 13,346 at the 2000 census. , with R&D, operations and manufacturing facilities for LabChip devices in Mountain View, California For the census-designated place, see Mountain View, Contra Costa County, California. For other places called "Mountain View", see . Mountain View is a city in Santa Clara County, in the U.S. state of California. The city gets its name from the views of the Santa Cruz Mountains. , and direct sales, service and applications support throughout the world. Caliper customers and partners include many of the largest pharmaceutical, biotechnology, and life sciences companies Caliper Life Sciences, Inc. +1-650-279-2088 www.caliperLS.com Agilent Technologies Inc. +1-408-553-7191 www.agilent.com |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion